{"altmetric_id":4448297,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":2},"blogs":{"unique_users_count":1,"unique_users":[422],"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["salimka00"],"posts_count":1}},"selected_quotes":["Flibanserin Approved for Low Sexual Desire in Premenopausal Women this carries side effects too !"],"citation":{"altmetric_jid":"4f6fa62b3cf058f610007f3d","doi":"10.1056\/nejm-jw.na38866","first_seen_on":"2015-08-29T01:13:45+00:00","issns":["1533-7820"],"journal":"Journal Watch","last_mentioned_on":1443510000,"links":["http:\/\/www.jwatch.org\/na38866\/2015\/08\/27\/flibanserin-approved-low-sexual-desire-premenopausal-women#sthash.5bOkhLA1.uxfs&st_refDomain=&st_refQuery=","http:\/\/www.jwatch.org\/na38866\/2015\/08\/27\/flibanserin-approved-low-sexual-desire-premenopausal-women"],"pubdate":"2015-08-27T00:00:00+00:00","publisher":"Journal Watch","title":"Flibanserin Approved for Low Sexual Desire in Premenopausal Women","type":"article"},"altmetric_score":{"score":11.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":11.5},"context_for_score":{"all":{"total_number_of_other_articles":6417267,"mean":5.8794758110387,"rank":499275,"this_scored_higher_than_pct":92,"this_scored_higher_than":5913363,"rank_type":"exact","sample_size":6417267,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":198001,"mean":9.4520781515152,"rank":25349,"this_scored_higher_than_pct":87,"this_scored_higher_than":172429,"rank_type":"exact","sample_size":198001,"percentile":87},"this_journal":{"total_number_of_other_articles":9047,"mean":3.9654015034269,"rank":711,"this_scored_higher_than_pct":92,"this_scored_higher_than":8332,"rank_type":"exact","sample_size":9047,"percentile":92},"similar_age_this_journal_3m":{"total_number_of_other_articles":626,"mean":4.8555584,"rank":67,"this_scored_higher_than_pct":89,"this_scored_higher_than":559,"rank_type":"exact","sample_size":626,"percentile":89}}},"demographics":{"poster_types":{"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1}}},"geo":{"twitter":{"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/salimka00\/statuses\/637432834093805568","license":"gnip","citation_ids":[4448297],"posted_on":"2015-08-29T01:13:25+00:00","author":{"name":"Kasim Salim","image":"https:\/\/pbs.twimg.com\/profile_images\/469518463174975488\/ByNImKIW_normal.jpeg","description":"Former Professor of Medicine\/ Hematology Calicut Medical School, Kerala, India and King Khalid University College of Medicine, Abha, Saudi Arabia.","id_on_source":"salimka00","tweeter_id":"107358139","geo":{"lt":52.48142,"ln":-1.89983,"country":"GB"},"followers":288},"tweet_id":"637432834093805568"}],"blogs":[{"title":"\u201cFemale Viagra?\u201d Misleading Headlines and Regulatory Dilemmas","url":"https:\/\/www.sciencebasedmedicine.org\/female-viagra-misleading-headlines-and-regulatory-dilemmas\/","license":"public","citation_ids":[4448297],"posted_on":"2015-09-29T07:00:00+00:00","summary":"The FDA recently approved flibanserin (brand name Addyi) for the treatment of hypoactive sexual desire disorder (HSDD) in pre-menopausal women. The story of flibanserin illustrates several of the issues we have confronted on this blog:\nIt was hyped in the","author":{"name":"Science-Based Medicine","url":"http:\/\/www.sciencebasedmedicine.org\/","description":"Exploring issues and controversies in the relationship between science and medicine"}}]}}